XML 16 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accounting for Shared-Based Payments (Details 2) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 69 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Stock options
Exercise price per Share 0.44 - 20.01
Sep. 30, 2014
Stock options
Exercise price per share 4.24 - 5.97
Sep. 30, 2014
Stock options
Exercise price per share 3.40 - 3.95
Sep. 30, 2014
Stock options
Exercise price per share 8.34 - 20.01
Sep. 30, 2014
Stock options
Exercise price per share 0.44 - 13.90
Sep. 30, 2014
Stock options
Exercise price per share 0.44 - 13.90
Contingent vesting
Number of Options                    
Granted (in shares)           1,664,000        
Exercised (in shares)             (9,999)      
Forfeited (in shares)               (110,190)    
Balance outstanding, end of period (in shares)         11,324,049       12,867,860 4,364,000
Exercisable at the end of the period (in shares)                 5,880,483  
Exercise Price Per Share                    
Exercise price, low end of the range (in dollars per share)         $ 0.44 $ 3.70 $ 3.40 $ 8.34 $ 0.44  
Exercise price, high end of the range (in dollars per share)         $ 20.01 $ 5.97 $ 3.95 $ 20.01 $ 13.90  
Weighted Average Exercise Price Per Share                    
Granted (in dollars per share)           $ 4.63        
Exercised (in dollars per share)             $ 3.58      
Forfeited (in dollars per share)               $ 17.51    
Balance outstanding, end of period (in dollars per share)         $ 3.31       $ 3.36 $ 0.70
Exercisable at the end of the period (in dollars per share)                 $ 2.96  
Intrinsic Value                    
Intrinsic value of options outstanding (in dollars)         $ 37,521,000       $ 7,555,000  
Intrinsic value of options exercised (in dollars)             23,000      
Intrinsic value of options exercisable (in dollars)                 4,552,000  
Weighted Average Remaining Contractual Term                    
Balance at the end of the period         6 years 11 months 9 days       6 years 8 months 9 days  
Exercisable at the end of the period                 5 years 10 months 28 days  
Additional disclosures                    
Total stock-based compensation expense (in dollars) $ 922,000 $ 1,090,000 $ 3,187,000 $ 3,258,000           $ 0